Grant: Discovery Grants Program - Individual
University of Guelph
$31,000.00
The early development of leptin and adiponectin resistance in skeletal muscle - a possible protective mechanism
FY 2015-16
Summary
Leptin and adiponectin are adipokines that improve insulin response in skeletal muscle, an effect attributed to their ability to stimulate fatty acid (FA) oxidation and decrease lipid accumulation. Conditions in which insulin resistance occurs, such as obesity, are characterized by a resistance to the stimulatory effects of leptin and adiponectin on FA oxidation. Resistance to these adipokines can be induced within days of administering a high fat diet, and precedes intramuscular lipid accumulation and impaired insulin response. Thus, it is tempting to speculate that the rapid development of resistance to these adipokines is an initiating event in the early development of impaired insulin signalling in muscle. However, findings of recent studies have challenged the dogma that impaired mitochondrial FA oxidation is the cause of impaired insulin response in muscle. Others have hypothesized that an excessive rate of FA ß-oxidation secondary to increased lipid availability may generate various deleterious species, such as reactive oxygen species (ROS), which can potentially damage many cellular proteins including those of the insulin signalling cascade. Notably, ROS are elevated in muscle after only 3 days of high fat feeding. It is our view that the rapid development of leptin and adiponectin resistance during the administration of a high fat diet is not the cause of impaired insulin signalling, but rather a protective mechanism to limit excessive FA entry into the mitochondrion and subsequent ROS production. The following series of experiments will test our general working hypothesis that ROS production is an important controller of leptin and adiponectin's ability to stimulate mitochondrial FA uptake.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
217437-2011
Name nom
Dyck, David
Department département
Human Health and Nutritional Sciences
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2011
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal physiology and metabolism
Research subject fr
Physiologie et métabolisme des animaux
Partie
5
Nb partie
5
Application title
The early development of leptin and adiponectin resistance in skeletal muscle - a possible protective mechanism
Keyword
NSERC
Application summary
Leptin and adiponectin are adipokines that improve insulin response in skeletal muscle, an effect attributed to their ability to stimulate fatty acid (FA) oxidation and decrease lipid accumulation. Conditions in which insulin resistance occurs, such as obesity, are characterized by a resistance to the stimulatory effects of leptin and adiponectin on FA oxidation. Resistance to these adipokines can be induced within days of administering a high fat diet, and precedes intramuscular lipid accumulation and impaired insulin response. Thus, it is tempting to speculate that the rapid development of resistance to these adipokines is an initiating event in the early development of impaired insulin signalling in muscle. However, findings of recent studies have challenged the dogma that impaired mitochondrial FA oxidation is the cause of impaired insulin response in muscle. Others have hypothesized that an excessive rate of FA ß-oxidation secondary to increased lipid availability may generate various deleterious species, such as reactive oxygen species (ROS), which can potentially damage many cellular proteins including those of the insulin signalling cascade. Notably, ROS are elevated in muscle after only 3 days of high fat feeding. It is our view that the rapid development of leptin and adiponectin resistance during the administration of a high fat diet is not the cause of impaired insulin signalling, but rather a protective mechanism to limit excessive FA entry into the mitochondrion and subsequent ROS production. The following series of experiments will test our general working hypothesis that ROS production is an important controller of leptin and adiponectin's ability to stimulate mitochondrial FA uptake.